Articles with "nanocarrier based" as a keyword



Photo by corey_lyfe from unsplash

Recent approaches in nanocarrier-based therapies for neglected tropical diseases.

Sign Up to like & get
recommendations!
Published in 2022 at "Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"

DOI: 10.1002/wnan.1852

Abstract: Neglected tropical diseases (NTDs) remain major public health problems in developing countries. Reducing the burden of NTDs requires sustained collaborative drug discovery efforts to achieve the goals of the new NTDs roadmap launched by the… read more here.

Keywords: tropical diseases; nanocarrier based; recent approaches; neglected tropical ... See more keywords
Photo by bernardhermant from unsplash

Nanocarrier-Based Biological Fluorescent Probes for Simultaneous Detection of Ketamine and Amphetamine in Latent Fingermarks

Sign Up to like & get
recommendations!
Published in 2019 at "Nano"

DOI: 10.1142/s1793292019500267

Abstract: Nanocarrier-based biological fluorescent probes for ketamine and amphetamine have been prepared by conjugating red and green fluorescent nanoparticles (150-nm-sized) with anti-ketamine and anti-amphetamine antibodies, respectively, with the assistance of carbodiimide/[Formula: see text]-hydroxysuccinimide. Biological fluorescent probes… read more here.

Keywords: amphetamine; nanocarrier based; fluorescent probes; biological fluorescent ... See more keywords
Photo by jupp from unsplash

Nanocarrier Based Delivery of Berberine: A Critical Review on Pharmaceutical and Preclinical Characteristics of the Bioactive.

Sign Up to like & get
recommendations!
Published in 2023 at "Current pharmaceutical biotechnology"

DOI: 10.2174/1389201024666230112141330

Abstract: Berberine (BBR) is an isoquinoline alkaloid with several therapeutic properties, including anti-microbial, anti-diarrhea, anti-viral, anti-inflammatory, antihypertensive, anti-tumor, and anti-diabetes. However, its low water solubility, low absorption, first-pass metabolism, non-targeting, and poor bioavailability represent major hurdles… read more here.

Keywords: delivery berberine; nanocarrier based; based delivery; berberine ... See more keywords
Photo by jupp from unsplash

Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.

Sign Up to like & get
recommendations!
Published in 2023 at "Nanomedicine"

DOI: 10.2217/nnm-2022-0250

Abstract: Hepatocellular carcinoma (HCC) poses a severe threat to human health and economic development. Despite many attempts at HCC treatment, most are inevitably affected by the genetic instability and variability of tumor cells. Arsenic trioxide (ATO)… read more here.

Keywords: based delivery; hepatocellular carcinoma; nanocarrier based; arsenic trioxide ... See more keywords
Photo by joshuafernandez from unsplash

Nanocarrier-Based Targeted Therapies for Myocardial Infarction

Sign Up to like & get
recommendations!
Published in 2022 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics14050930

Abstract: Myocardial infarction is a major cause of morbidity and mortality worldwide. Due to poor inherent regeneration of the adult mammalian myocardium and challenges with effective drug delivery, there has been little progress in regenerative therapies.… read more here.

Keywords: targeted therapies; nanocarrier based; myocardial infarction; infarction ... See more keywords
Photo by bneale87 from unsplash

Essential oil and nanocarrier based formulations approaches for vaginal candidiasis.

Sign Up to like & get
recommendations!
Published in 2023 at "Therapeutic delivery"

DOI: 10.4155/tde-2022-0058

Abstract: An exclusive site for local drug delivery is the vagina, especially for vaginal infections. The fungus Candida albicans causes vaginal infection known as vulvovaginal candidiasis, a highly prevalent and recurrent gynaecological disease among women. Vaginal… read more here.

Keywords: nanocarrier based; candidiasis; essential oil; vaginal candidiasis ... See more keywords
Photo by polarmermaid from unsplash

Nanocarrier-based drug combination therapy for glioblastoma

Sign Up to like & get
recommendations!
Published in 2020 at "Theranostics"

DOI: 10.7150/thno.38147

Abstract: The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem cells, drug efflux pumps and DNA damage repair mechanisms. Drug… read more here.

Keywords: combination; glioblastoma; nanocarrier based; drug ... See more keywords